HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eileen O'Meara Selected Research
Eileen O'Meara Research Topics
Disease
106
Heart Failure
03/2024 - 08/2004
8
Atrial Fibrillation
03/2024 - 01/2010
7
Heart Arrest (Cardiac Arrest)
11/2021 - 04/2014
6
Iron Deficiencies
01/2024 - 12/2010
6
Cardiomyopathies (Cardiomyopathy)
12/2023 - 12/2019
6
Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2019
5
Left Ventricular Dysfunction
02/2024 - 10/2011
5
Inflammation (Inflammations)
01/2024 - 01/2012
5
Chronic Renal Insufficiency
01/2022 - 12/2010
5
Hyperkalemia
01/2019 - 04/2014
5
Anemia
01/2015 - 12/2004
4
Myocardial Infarction
01/2022 - 12/2007
4
Hypokalemia
01/2019 - 04/2014
3
Fibrosis (Cirrhosis)
01/2023 - 12/2011
3
Stroke (Strokes)
01/2022 - 01/2020
3
Systolic Heart Failure
01/2021 - 11/2013
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 11/2017
2
Frailty
01/2023 - 01/2020
2
Heart Diseases (Heart Disease)
01/2022 - 01/2018
2
Mitral Valve Insufficiency (Mitral Regurgitation)
01/2020 - 10/2017
2
Hypertension (High Blood Pressure)
12/2019 - 05/2012
2
Death (Near-Death Experience)
11/2017 - 05/2011
1
Dyspnea (Shortness of Breath)
01/2024
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2024
1
Cardio-Renal Syndrome
01/2023
1
Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2023
1
Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
10/2022
1
Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2022
1
Gout
01/2022
1
Hypoglycemia (Reactive Hypoglycemia)
01/2021
1
Ketosis
01/2021
1
Amyloidosis
01/2020
1
Transthyretin-Related Hereditary Amyloidosis
01/2020
1
Pulmonary Hypertension
12/2019
Drug/Important Bio-Agent (IBA)
27
Mineralocorticoid Receptor Antagonists
IBA
01/2022 - 12/2011
23
dapagliflozin
IBA
12/2023 - 11/2019
18
Spironolactone (Aldactone)
FDA Link
Generic
01/2022 - 08/2004
15
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2012
8
Natriuretic Peptides
IBA
12/2023 - 09/2014
8
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2022 - 12/2013
8
candesartan
IBA
12/2019 - 11/2004
7
sacubitril and valsartan sodium hydrate drug combination
IBA
07/2023 - 01/2018
6
Neprilysin (Neutral Endopeptidase)
IBA
03/2024 - 01/2015
6
Angiotensin Receptors (Angiotensin II Receptor)
IBA
03/2024 - 01/2015
6
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 10/2018
5
omecamtiv mecarbil
IBA
12/2023 - 11/2020
5
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2022 - 11/2019
5
Sodium-Glucose Transport Proteins
IBA
01/2022 - 11/2019
5
pro-brain natriuretic peptide (1-76)
IBA
01/2022 - 09/2014
5
Creatinine
IBA
11/2018 - 12/2010
4
ferric carboxymaltose
IBA
01/2024 - 01/2021
4
Sodium
IBA
01/2023 - 01/2020
4
Troponin T (Troponin T1)
IBA
01/2022 - 09/2014
4
Diuretics
IBA
01/2020 - 12/2013
4
Ivabradine
IBA
12/2019 - 10/2011
4
Angiotensin Receptor Antagonists
IBA
05/2018 - 11/2004
3
paragon
IBA
02/2024 - 01/2018
3
Iron
IBA
12/2023 - 12/2010
3
Cardiac Myosins
IBA
01/2021 - 11/2020
2
omega-Chloroacetophenone (Mace)
IBA
01/2024 - 01/2022
2
Growth Differentiation Factor 15
IBA
01/2023 - 12/2018
2
Ferritins (Ferritin)
IBA
01/2022 - 12/2010
2
Troponin
IBA
01/2022 - 11/2018
2
Transferrin (beta 2 Transferrin)
IBA
01/2022 - 12/2010
2
Transferrin Receptors (Transferrin Receptor)
IBA
01/2022 - 12/2010
2
Glucagon-Like Peptide-1 Receptor Agonists
IBA
01/2022 - 01/2022
2
Irbesartan
FDA Link
Generic
12/2019 - 01/2017
2
Enalapril
FDA Link
Generic
01/2019 - 12/2018
2
Hemoglobins (Hemoglobin)
IBA
05/2018 - 02/2006
2
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
05/2018 - 05/2012
2
Potassium
IBA
05/2018 - 01/2015
2
Anticoagulants
IBA
01/2016 - 05/2012
1
C-Reactive Protein
IBA
01/2024
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2024
1
Carbohydrates
IBA
11/2023
1
Antigens
IBA
11/2023
1
Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)
IBA
01/2023
1
Clostridium perfringens epsilon-toxin
IBA
01/2022
1
Symporters
IBA
01/2022
1
4-S-(propionic acid)sulfidocyclophosphamide (PASP)
IBA
01/2022
1
Uric Acid (Urate)
IBA
01/2022
1
Erythropoietin
FDA Link
01/2022
1
Hepcidins
IBA
01/2022
1
Carbon Dioxide
IBA
01/2022
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2021
1
Galectin 3 (LGALS3)
IBA
01/2021
1
Collagen Type III (Type III Collagen)
IBA
01/2021
1
Prealbumin (Transthyretin)
IBA
01/2020
1
tafamidis
IBA
01/2020
Therapy/Procedure
35
Therapeutics
03/2024 - 12/2004
5
Transjugular Intrahepatic Portasystemic Shunt
01/2021 - 03/2014
3
Drug Therapy (Chemotherapy)
01/2023 - 01/2022
3
Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2022 - 05/2012
2
Cardiac Resynchronization Therapy
10/2017 - 12/2011
1
Contraindications
01/2023
1
Patient Readmission
10/2022
1
Polypharmacy
11/2021
1
Surgical Amputation (Amputations)
01/2021
1
Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2019